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Human genetic variation is an important determinant of the
outcome of infection with Mycobacterium tuberculosis. We have
conducted a two-stage genome-wide linkage study to search for
regions of the human genome containing tuberculosis-suscep-
tibility genes. This approach uses sibpair families that contain
two full siblings who have both been affected by clinical
tuberculosis. For any chromosomal region containing a major
tuberculosis-susceptibility gene, affected sibpairs inherit the
same parental alleles more often than expected by chance. In the
first round of the screen, 299 highly informative genetic mark-
ers, spanning the entire human genome, were typed in 92
sibpairs from The Gambia and South Africa. Seven chromosomal
regions that showed provisional evidence of coinheritance with
clinical tuberculosis were identified. To identify whether any of
these regions contained a potential tuberculosis-susceptibility
gene, 22 markers from these regions were genotyped in a
second set of 81 sibpairs from the same countries. Markers on
chromosomes 15q and Xq showed suggestive evidence of link-
age (lod 5 2.00 and 1.77, respectively) to tuberculosis. The
potential identification of susceptibility loci on both chromo-
somes 15q and Xq was supported by an independent analysis
designated common ancestry using microsatellite mapping.
These results indicate that genome-wide linkage analysis can
contribute to the mapping and identification of major genes for
multifactorial infectious diseases of humans. An X chromosome
susceptibility gene may contribute to the excess of males with
tuberculosis observed in many different populations.
One-third of the world’s population is estimated to beinfected with Mycobacterium tuberculosis (1). Half of those
exposed to the organism become infected (2), but only 1 in 10
persons who become infected will ever develop clinical disease
(3). In only a minority of cases is there an obvious identifiable
risk factor such as diabetes, advanced age, alcohol abuse, HIV
infection, or corticosteroid usage. In the remainder, a complex
interaction of genetic and environmental factors causes the
development of clinical tuberculosis. There is substantial evi-
dence from studies on racial variation in susceptibility to tuber-
culosis (4, 5) and twin studies (6, 7) that host genetic factors are
important in determining the susceptibility to infection with M.
tuberculosis and the subsequent development of clinical dis-
ease.†† In a large case-control study in Gambians, including over
800 subjects, we have shown that genetic variants of the natural
resistance-associated macrophage protein (NRAMP1) and vita-
min D receptor (VDR) genes are associated with smear-positive
pulmonary tuberculosis (8, 9). However, together, these can only
account for a small proportion of the overall genetic component
suggested by twin studies.
It is now possible to screen the entire human genome for genes
exerting a major effect on susceptibility to multifactorial dis-
eases, and several complete screens of non-infectious disease
have now been completed (10–19). These studies represent a
systematic approach to finding genes that exert a high locus-
specific sibling recurrence risk (ls). For example, simulation
analyses have shown that there is a 99.9% chance of obtaining a
maximum lod score .2.3 for a locus with ls 5 2.5 by using
markers spaced at approximately 11-centimorgan intervals and
96 affected sibpair families (10). However, whether such an
approach would be valuable in common infectious diseases, most
of which may be highly polygenic, is unknown.
Segregation analysis of families with multiple cases of tuber-
culosis in Brazil has suggested that there are one or two major
genes determining individual tuberculosis-susceptibility (20), at
least in such selected pedigrees. We have conducted a two stage
genome-wide search on 136 families, including 173 sibpairs,
affected by clinical tuberculosis from The Gambia and South
Africa to attempt to localize any genes exerting a major effect on
risk of this disease. No marker was strongly linked to disease,
indicating that tuberculosis-susceptibility is not a monogenic
disease in Africans. Two regions on chromosomes 15q and Xq
showed suggestive evidence of linkage to tuberculosis. The
presence of susceptibility genes on these chromosomes was
supported by an independent analysis that we term common
ancestry using microsatellite (CAM) mapping. Collectively,
these data and analysis support the localization of novel tuber-
culosis susceptibility genes in both of these chromosomal
regions.
Materials and Methods
Design of Family Studies. Families with two or more siblings
affected by tuberculosis were identified from the records of all
nine tuberculosis clinics located throughout The Gambia, from
four clinics around Tygerberg Hospital in the Western Cape,
South Africa and from Hlabisa Hospital, KwaZulu-Natal. Mic-
rosatellites [genetic markers consisting of a (CA)n sequence with
marked length variation] were used to screen the entire human
genome in a two stage process. In the first round, 288 micro-
satellite markers were typed in 67 Gambian families including 73
fully independent sibpairs and 16 KwaZulu-Natal families in-
cluding 19 independent sibpairs. A further 11 markers on
chromosomes 15q and Xq were then typed to increase the
marker density in these two regions. The second round of the
Abbreviations: CAM mapping, common ancestry using microsatellite mapping; lod, loga-
rithm of odds.
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screen using 22 microsatellite markers was conducted on 12
Gambian sibpair families and 41 families from the Western Cape
including 69 independent sibpairs (table 1). Both parents of the
affected siblings were typed if available. When parental samples
were not available, unaffected siblings were recruited to the
study to reconstruct parental genotypes. In the first round
screen, 33 Gambian families included 2 parents, 20 families only
one parent, and 14 families no parents and, in KwaZulu-Natal,
9 families included both parents and 7 families one parent. In the
second screen, 6 Gambian families had both parents, 3 families
1 parent, and 3 families no parents available and, in the Western
Cape, 12 families had two parents, 17 families 1 parent, and 12
families no parents.
Patient Characteristics. The Gambia has seven principal ethnic
groups that have been shown to be closely genetically related
(21). The patients recruited from KwaZulu-Natal were all Zulus,
and the patients from the Western Cape belonged to the racial
group previously designated Cape Coloureds.
Of 164 affected siblings from The Gambia, 102 had smear-
positive pulmonary disease. The other patients were diagnosed
by experienced clinicians and were only included in the study if
they fulfilled all three of the following criteria: (i) significant
symptoms consistent with a diagnosis of tuberculosis (at least
two of the following: loss of .10% body weight, chronic cough
every day for .4 weeks, prolonged fever or night sweats for .4
weeks, and significant cervical lymphadenopathy); (ii) a known
smear-positive tuberculosis contact; and (iii) a chest x-ray con-
sistent with active disease (alveolar infiltrates with or without
cavitation) unless extrapulmonary disease was diagnosed. Cul-
ture facilities for acid fast bacilli were not available at the time
of the study. Fifty-one patients were under 16 years old at the
time of diagnosis. The Gambia has a much lower incidence of
HIV infection than is found in the majority of sub-Saharan
Africa, and less than 2% of the general population are HIV
positive. Patients who gave their consent (.95%) were screened
for HIV antibodies, and only three affected siblings tested
positive.
All affected siblings from the Western Cape had positive
sputum smears andyor culture, and all were tested for HIV
antibodies. No patients were HIV-positive, a reflection of the
low prevalence of HIV in this community (22). Two affected
siblings were less than 16 years old. Of 35 affected siblings from
KwaZulu-Natal, 15 were sputum smear-positive, and the remain-
der were diagnosed by experienced clinicians, using the criteria
described above. Seven patients were HIV-positive, and thirteen
siblings were less than 16 years old.
Genotyping. Two hundred and ninety-nine highly polymorphic
microsatellite markers (mean heterozygosity 0.83 in these
populations) covering all 22 autosomes and the X chromosome
were typed in the first round screen. The average interval
between adjacent markers was ,11 centimorgans, and ,0.5%
of the genome was .20 centimorgans from the nearest marker,
according to the Genethon linkage map (23). Microsatellite
genotyping was performed by using f luorescence-based semi-
automated technology as described by Reed et al. (24). PCR
conditions were optimized for each set of f luorescence-labeled
primers by using a range of annealing temperatures (50–61°C)
and magnesium concentrations (1.0–3.0 mM) on MJ Research
machines. The 15-ml total reaction mix contained 50 ng of
DNA, 40 ng of each primer, 2.5 mmol of potassium chloride
buffer, 100 mM dNTPs, 1.0–3.0 mM MgCl2, and 0.2 units of
Taq polymerase. Pooled amplified PCR products were elec-
trophoresed through 6% acrylamide gels on 373A DNA se-
quencers (Perkin–Elmer). DNA fragment sizing was per-
formed by using the GENESCAN 672 and GENOTYPER software
programs (Perkin–Elmer).
Statistical Analysis. The statistical methodology underlying ge-
nome-wide linkage analysis is discussed in ref. 25. For each
individual marker, affected sibpair analysis was performed with
the SIBPAIR ANALYSIS program (16). SIBPAIR ANALYSIS provides
a likelihood-based test statistic for linkage that is equivalent to
the lod score calculated assuming recessive disease and phase
unknown matings. When parental genotypes are not available,
the likelihood is a sum of terms corresponding to each of the
possible parental genotype combinations using genotype fre-
quencies calculated assuming Hardy-Weinberg equilibrium and
including information from affected and unaffected offspring.
Segregation of alleles to unaffected offspring is assumed to be
Mendelian (16). Because it is impossible to be sure that unaf-
fected siblings are resistant to tuberculosis, affected-unaffected
sibling pairs were not used in linkage analysis.
Maximum-likelihood multipoint mapping was performed by
using MAPMAKERySIBS (26). This is a multipoint method based
on the single-point affected pedigree member lod score
method of Risch (27, 28). Only fully independent affected
sibpairs were utilized in the analysis, and maximum likelihood
lod scores were calculated by using the possible triangle
constraints (29). The program uses genotype information for
each affected sibpair, with information from parents and
unaffected sibs where available, to infer the identity-by-
descent distribution for each point along a chromosome (26).
Multipoint mapping is more powerful than single marker
analysis as more families are informative in the linkage
analysis. For the X chromosome, lod scores are calculated
separately for brother-brother, brother-sister, and sister-sister
pairs and then combined. Any marker that showed a lod score
.1 on SIBPAIR ANALYSIS or any region that showed a lod .1
on MAPMAKERySIBS on the first round of the screen was
followed up in the second round. Exclusion maps (regions with
a very low probability of containing a tuberculosis-
susceptibility gene) were produced for a putative disease-
susceptibility gene with ls 5 2.0, assuming no dominance
variance using MAPMAKERySIBS.
The technique of common ancestry using microsatellite
(CAM) mapping was also used to analyze the data. This
method is described in further detail elsewhere (W.A., R.B., G.
Cooper, and A.V.S.H., unpublished work). Whereas tradi-
tional linkage analysis treats both alleles at a locus indepen-
dently, CAM mapping focuses on the inherited genotype. In
essence, CAM mapping is an extended form of homozygosity
mapping that looks for an association between disease inci-
dence and regions of high homozygosityyheterozygosity. How-
ever, whereas homozygosity mapping treats each marker in-
dependently, CAM mapping looks at patterns of relatedness
among all markers on the same chromosome. The principle of
CAM mapping is as follows. In any population, the expected
Table 1. Number of families and sibpairs in two-stage genome
screen
Number of families with:
First screen Second screen
The
Gambia
South
Africa
The
Gambia
South
Africa
Two affected siblings 61 13 12 21
Three affected siblings 6 3 0 14
Four affected siblings 0 0 0 5
Six affected siblings 0 0 0 1
Total families 67 16 12 41
Total sibpairs 73 19 12 69
The number of fully independent sibpairs in each family is equal to the
number of affected siblings minus one.
8006 u www.pnas.org Bellamy et al.
time to most recent common ancestor (‘‘time depth’’) will be
the same for every gene. However, recombination, indepen-
dent assortment of chromosomes, and genetic drift together
ensure that time depth varies greatly among genes about this
expectation. Similarly, the average time depth for entire
chromosomes will vary, both among chromosomes in the same
population and for any given chromosome in different sub-
populations. Given this variation, genes on the same pair of
homologous chromosomes will tend to have more similar time
depths than expected by chance, simply by dint of being from
the same subpopulation. In other words, time depth is corre-
lated on homologous pairs. Given this time depth correlation,
individuals who are homozygous at one locus on a particular
chromosome will tend to show lower mean time depth for all
other markers on that chromosome. Thus, a chromosome that
carries a homozygous disease susceptibility factor can be
identified by its lower mean time depth in affected relative to
unaffected individuals. In CAM mapping, data from micro-
satellite-based genome screens are used to compare average
time depths in cases and controls. Chromosomes that exhibit
a large, disease-status-dependent difference in time depth are
considered candidates for the location of susceptibility factors.
Furthermore, individual markers were compared to facilitate
the localization of susceptibility genes on a chromosome. In
any individual at any locus, the genetic distance between
parental genomes is calculated as the squared difference in
allele length, d (2). These differences are then compared in
affected versus unaffected and transmitted versus nontrans-
mitted genotypes by using a simple t test to generate a statistic
that ref lects the magnitude and direction of the difference.
Precise significance levels have yet to be determined, but work
to date suggests that values exceeding 1.5 should be treated as
large and significant (data not shown).
Results
In the first round of the genome screen, conducted on 92
independent sibpairs, seven regions on chromosomes 3, 5, 6, 8,
9, 15, and X showed nominal evidence for linkage (lod .1.0)
using MAPMAKERySIBS and SIBPAIR ANALYSIS. Twenty-two mark-
ers from these regions were typed in a second round screen on
a further 81 independent sibpairs. Two regions, on chromosomes
15q and Xq, showed evidence of linkage to putative tuberculosis-
susceptibility genes in the combined analysis (table 2). For
chromosomes 15 and X, multipoint lod scores were produced for
the combined screens by using MAPMAKERySIBS (Fig. 1). The
maximum multipoint lod scores for these regions are 1.82 and
2.18, respectively. There is a difference between the maximum
lod score for the X chromosome produced by the two programs
(1.77 at CD40l for SIBPAIR ANALYSIS and 2.18 for MAPMAKERy
SIBS at DXS1227). This is because MAPMAKERySIBS analyzes the
data for brother-brother, brother-sister, and sister-sister pairs
separately and then combines lod scores. lod scores cannot be
less than zero, so if one pairing produces allele sharing of less
than the expected 0.5, this is ignored. Thus, we prefer the more
conservative estimate for the X chromosome produced by
SIBPAIR ANALYSIS. The apparent lower lod scores for D15S1007
and D15S1002 in the single locus analysis (Table 2) compared
with the multipoint analysis (Fig. 1) are caused by low marker
information content.
No region of the genome showed strong evidence (e.g., a lod
score . 3.0) of linkage to tuberculosis in these African popu-
lations. This indicates that tuberculosis-susceptibility in our
Table 2. Individual marker linkage analysis for tuberculosis
Marker
Screen 1 Screen 2 Combined analysis
lod P value lod P value lod P value
D15S1035 1.03 0.015 0.66 0.041 1.64 0.003
D15S128 1.43 0.005 0.60 0.048 2.00 0.001
D15S1002 0.00 0.50 1.04 0.001 0.39 0.090
D15S165 0.017 0.39 0.72 0.035 0.51 0.063
D15S1007 0.24 0.14 0.24 0.15 0.50 0.065
CD40l 0.71 0.035 1.00 0.016 1.77 0.002
DXS8094 0.64 0.040 0.77 0.030 1.49 0.004
DXS8072 0.00 0.50 0.15 0.21 0.08 0.27
DXS1192 0.27 0.13 0.52 0.060 0.71 0.035
DXS1232 0.082 0.27 0.55 0.056 0.61 0.047
DXS984 0.17 0.19 0.87 0.022 0.98 0.017
DXS1227 0.00 0.50 0.17 0.19 0.086 0.27
DXS8043 0.029 0.36 0.077 0.28 0.11 0.24
Analyses were performed by using SIBPAIR ANALYSIS for each individual marker. Markers are shown in order of
position along chromosome.
Fig. 1. Multipoint maximum lod score analysis for chromosomes 15 and X for
combined screen 1 and 2 data, calculated by using MAPMAKERySIBS.
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populations is not a monogenic trait. Multipoint exclusion
mapping was performed on data from the first round screen for
a putative tuberculosis-susceptibility gene with a ls 5 2.0 or 3.0
by using MAPMAKERySIBS. The majority of the genome could not
be excluded for a ls 5 2.0, but 78% of the genome could be
excluded for a gene with a ls 5 3.0 (30). Therefore, a gene
exerting a moderate population-wide sibling recurrence risk for
tuberculosis could have been missed by this genome screen.
For the markers on chromosomes other than 15 and X,
combined analysis of the first and second rounds of the screen
produced a lod score of less than 0.7. These regions are unlikely
to contain a major tuberculosis-susceptibility gene unless there
is significant heterogeneity between tuberculosis-susceptibility
in The Gambia and South Africa. None of these markers
produced a lod score of more than 1.5 when The Gambian
families alone were analyzed (30).
In view of the suggestive evidence of tuberculosis susceptibility
genes on chromosomes 15q and Xq provided by linkage analysis,
we proceeded to analyze the same dataset by using a form of
homozygosity mapping termed common ancestry using micro-
satellites (CAM) mapping. This independent analysis identified
both chromosomes 15 and X as showing a significant excess of
homozygosity in the tuberculosis cases compared with controls
(data not shown). The concordance between linkage analysis
and CAM analysis was equally striking when individual markers
were compared. Of all of the microsatellite markers studied
across the genome, three of the five highest scores on CAM
analysis (Table 3) were for makers lying in the regions of linkage
on chromosomes 15q and Xq (Fig. 1; Table 2).
Discussion
A variety of different approaches have previously been used to
identify genes involved in host susceptibility to infectious dis-
eases, including candidate gene studies on tuberculosis (8, 9, 31)
and malaria (32) and studies on inbred families with extreme
susceptibility to non-tuberculous mycobacteria (33). To date,
linkage studies have addressed only candidate genes or small
numbers of extended families with measurements of schistoso-
mal parasite burdens rather than disease (34, 35). Here, we
report a genome-wide search on a large number of families with
an infectious disease. The linkage analysis alone provides sug-
gestive evidence for tuberculosis-susceptibility genes on chro-
mosomes 15q and Xq, and these results are supported by the
results of the CAM mapping.
Complex segregation analysis on some Brazilian families
with multiple cases of tuberculosis rejected a polygenic model
of inheritance and suggested that only one or two genes were
important in determining susceptibility to disease (20). In our
study, no marker was strongly linked to disease, indicating that
there is unlikely to be a single major tuberculosis-susceptibility
gene among Africans. Whether this apparent difference re-
lates to differences in tuberculosis-susceptibility between Bra-
zilians and Africans, the analysis of selected pedigrees in the
Brazilian study, or some of the inherent limitations of complex
segregation analysis (36), requires further investigation. Com-
bining the data from the three African populations could have
resulted in a gene exerting a major tuberculosis-susceptibility
effect in a single population being overlooked. However, when
the Gambian and South African families were evaluated
separately, no additional significantly linked loci were identi-
fied (30).
In a case-control study in The Gambia, two candidate genes,
NRAMP1 and VDR, were found to be associated with tuber-
culosis (8, 9), but, in the present family study, microsatellites
near to these genes were not found to be significantly genet-
ically linked to susceptibility. Although the patients in the
case-control study were clinically more homogeneous (all
HIV-negative adults with smear-positive pulmonary tubercu-
losis) than those in the family study, there is no inconsistency
between the datasets. NRAMP1 and VDR do not exert a large
enough familial clustering effect to produce statistically sig-
nificant evidence of linkage in this study. The nearest marker
to NRAMP1, D2S1471, had a weakly positive lod score of 0.47.
This issue has previously been discussed by Risch and Meri-
kangas, who showed that linkage analysis does not usually have
the power to identify disease-susceptibility loci conferring
genotype relative risks of around 2 (similar to NRAMP1) as
unrealistically large numbers of families would be required
(37). Conversely, this implies that the putative susceptibility
genes mapped to chromosomes 15q and Xq may have sub-
stantially larger effects than any tuberculosis susceptibility
locus implicated previously.
CAM analysis may be viewed as a more sensitive type of
homozygosity mapping. It employs a sensitive index of genetic
distance (d2) to identify chromosomes and chromosomal re-
gions that share more recent ancestry and thus can map
susceptibility loci that are recessive or (with less power)
codominant. Thus, using the same dataset, information in the
population structure of the families studied is extracted to
provide mapping information that is independent of linkage
analysis of the sibling pairs. In this first application of such a
combined analysis, a concordance in the results of linkage and
CAM mapping is observed, supporting the localization of
susceptibility genes on chromosomes 15q and Xq. For example,
the highest scoring individual markers from the whole genome
using CAM analysis (Table 3), D15S1035, is located in the
region of linkage on chromosome 15. The presence of high
CAM mapping scores in the regions of linkage argues that the
susceptibility genes suggested by linkage analysis are more
likely to be recessive, or at least codominant, rather than
dominant.
Positional candidate genes located in the region of interest
on chromosome 15 include the P protein and the HERC2 genes
(38, 39). Several candidate genes that lie in the region of
interest on the X chromosome, Xq26, particularly CD40
ligand, also warrant investigation. The microsatellite within
the CD40 ligand gene that was typed in this study did not show
evidence of transmission disequilibrium to affected offspring.
It is of note that there are approximately twice as many male
compared with female tuberculosis patients in both The
Gambia and South Africa (data not shown; ref. 40). This
significant male excess is consistently observed in many dif-
Table 3. Individual marker CAM mapping analysis for
tuberculosis
Microsatellite Score P value
D15S1035 3.63 0.0001
D14S63 2.69 0.004
D1S197 2.28 0.011
DXS1047 2.25 0.012
CD40l 2.21 0.014
DXS993 1.96 0.025
D11S903 1.79 0.037
D6S314 1.75 0.040
D8S285 1.75 0.040
D17S799 1.73 0.042
Results of calculating mean d2 for affected and unaffected individuals,
for every marker in turn in a time to most recent common ancestor analysis.
The 10 microsatellite markers with the highest scores are shown. Signifi-
cance was assessed by randomizing the data with respect to affected status
100 times. The score given to each marker is the observed difference
divided by the standard deviation of the randomizations, with P values
taken directly from the resulting z value (one-tailed, no adjustment for
multiple tests).
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ferent ethnic groups throughout the developing and industri-
ally developed world (41–44). Although this excess of male
patients could be attributable to a hormonal effect or to
environmental risk factors, it is also consistent with a tuber-
culosis-susceptibility gene on the X chromosome.
In summary, this study has found evidence against the prop-
osition that tuberculosis susceptibility is largely monogenic, at
least in these African populations. Two regions of the genome on
chromosomes 15q and Xq showed evidence of tuberculosis
susceptibility genes both by linkage and CAM mapping, and
further work toward gene identification in these regions is
indicated. The characterization of susceptibility genes with ef-
fects large enough to be detectable in whole genome screens
should provide new insights into the pathogenesis of this major
cause of global morbidity and mortality.
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